Literature DB >> 3918802

Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by tannic acid, hydroxylated anthraquinones and hydroxylated cinnamic acid derivatives.

M T Huang, R L Chang, A W Wood, H L Newmark, J M Sayer, H Yagi, D M Jerina, A H Conney.   

Abstract

Tannic acid and several hydroxylated anthraquinone and cinnamic acid derivatives inhibited the mutagenic activity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene (B[a]P 7,8-diol-9,10-epoxide-2), an ultimate mutagenic and carcinogenic metabolite of benzo [a]pyrene. The mutagenic activity of 0.05 nmol of B[a]P 7,8-diol-9,10-epoxide-2 towards strain TA 100 of Salmonella typhimurium was inhibited 50% by incubation of the bacteria and the diol-epoxide with tannic acid (0.5 nmol), anthraflavic acid (7 nmol), rufigallol (7 nmol), quinalizarin (10 nmol), alizarin (30 nmol), purpurin (60 nmol), and danthron (88 nmol). Dose-dependent, but weaker antimutagenic activity was observed for quinizarin, and a number of hydroxylated cinamic acid derivatives. Gallic acid and m-digallic acid, major components of tannic acid, possessed less than 1% of the anti-mutagenic activity of tannic acid, although m-digallic acid was over 3 times more active than gallic acid. The anti-mutagenic activity of tannic acid was a result of its interaction with B[a]P 7,8-diol-9,10-epoxide-2 since the rate of disappearance of the diol-epoxide from cell-free solutions in 1:9dioxane:water was markedly stimulated by the polyphenol. Tannic acid was a highly potent inhibitor of the mutagenic activity of the bay-region diol-epoxides of benzo[a]pyrene, dibenzo[a,h]pyrene and dibenzo[a,i]pyrene, but higher concentrations of tannic acid were needed to inhibit the mutagenicity of the chemically less reactive benzo[a]-pyrene 4,5-oxide and the bay-region diol-epoxides of benz[a]-anthracene, chrysene and benz[c]phenanthrene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918802     DOI: 10.1093/carcin/6.2.237

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid.

Authors:  R Dixit; B Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.

Authors:  M You; U Candrian; R R Maronpot; G D Stoner; M W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 3.  Nutraceutical interventions for promoting healthy aging in invertebrate models.

Authors:  Yuqing Dong; Sujay Guha; Xiaoping Sun; Min Cao; Xiaoxia Wang; Sige Zou
Journal:  Oxid Med Cell Longev       Date:  2012-09-06       Impact factor: 6.543

4.  Protective effects of the flavonoid chrysin against methylmercury-induced genotoxicity and alterations of antioxidant status, in vivo.

Authors:  Eduardo Scandinari Manzolli; Juliana Mara Serpeloni; Denise Grotto; Jairo Kennup Bastos; Lusânia Maria Greggi Antunes; Fernando Barbosa Junior; Gustavo Rafael Mazzaron Barcelos
Journal:  Oxid Med Cell Longev       Date:  2015-02-24       Impact factor: 6.543

5.  Isolation and characterization of antimutagenic components of Glycyrrhiza aspera against N-methyl-N-nitrosourea.

Authors:  Keiko Inami; Yusuke Mine; Jin Tatsuzaki; Chihiro Mori; Masataka Mochizuki
Journal:  Genes Environ       Date:  2017-01-06

6.  Mechanisms of Caffeine-Induced Inhibition of UVB Carcinogenesis.

Authors:  Allan H Conney; Yao-Ping Lu; You-Rong Lou; Masaoki Kawasumi; Paul Nghiem
Journal:  Front Oncol       Date:  2013-06-17       Impact factor: 6.244

7.  Stimulatory effects of sulfur and nitrogen oxides on carcinogen activation in human polymorphonuclear leukocytes.

Authors:  D Constantin; K Mehrotra; A Rahimtula; P Moldéus; B Jernström
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.